Targeting IL-1β as an immunopreventive and therapeutic modality for K-ras–mutant lung cancer

Bo Yuan(The University of Texas MD Anderson Cancer Center), Seyed Javad Moghaddam(The University of Texas MD Anderson Cancer Center)
JCI Insight
April 26, 2022
Cited by 78


Related Papers